Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...

After an elevated prostate-specific antigen (PSA) test, which helped screen for prostate cancer, left him reeling, longtime ...

After Amanda Peet reflected on her breast cancer diagnosis in a candid essay, her friend Sarah Paulson shared a message of ...

Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

Nurse-led bladder volume support improved radiotherapy reproducibility and reduced repeat imaging in prostate cancer. Read ...

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch ...

A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...

Clinical benefits of the talazoparib and enzalutamide combination extend to patients with both BRCA and non-BRCA homologous recombination repair gene alterations.